Priority Setting and Influential Factors on Acceptance of Pharmaceutical Recommendations in Collaborative Medication Reviews in an Ambulatory Care Setting – Analysis of a Cluster Randomized Controlled Trial (WestGem-Study)
Open Access
- 2 June 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (6) , e0156304
Abstract
Medication reviews are recognized services to increase quality of therapy and reduce medication risks. The selection of eligible patients with potential to receive a major benefit is based on assumptions rather than on factual data. Acceptance of interprofessional collaboration is crucial to increase the quality of medication therapy. The research question was to identify and prioritize eligible patients for a medication review and to provide evidence-based criteria for patient selection. Acceptance of the prescribing general practitioner to implement pharmaceutical recommendations was measured and factors influencing physicians’ acceptance were explored to obtain an impression on the extent of collaboration in medication review in an ambulatory care setting. Based on data of a cluster-randomized controlled study (WestGem-study), the correlation between patient parameters and the individual performance in a medication review was calculated in a multiple logistic regression model. Physician’s acceptance of the suggested intervention was assessed using feedback forms. Influential factors were analyzed. The number of drugs in use (p = 0.001), discrepancies between prescribed and used medicines (p = 0.014), the baseline Medication Appropriateness Index score (p0.05) and a low kidney function (p>0.05) do not predetermine the outcome. Longitudinal patient care with repeated reviews showed higher interprofessional acceptance and superior patient benefit. A total of 54.9% of the recommendations in a medication review on drug therapy were accepted for implementation. The number of drugs in use and medication reconciliation could be a first rational step in patient selection for a medication review. Most elderly, multimorbid patients with polymedication experience a similar chance of receiving a benefit from a medication review. Longitudinal patient care should be preferred over confined medication reviews. The acceptance of medication reviews by physicians supports further implementation into health care systems. ISRCTN ISRCTN41595373Keywords
Funding Information
- European Union and the state of North Rhine-Westphalia (GW2076)
This publication has 43 references indexed in Scilit:
- Adherence management for patients with cancer taking capecitabine: a prospective two-arm cohort studyBMJ Open, 2013
- Stepped wedge designs could reduce the required sample size in cluster randomized trialsJournal of Clinical Epidemiology, 2013
- US Pharmacists' Effect as Team Members on Patient CareMedical Care, 2010
- Pharmacist-Based Medication Review Reduces Potential Drug-Related Problems in the ElderlyDrugs & Aging, 2009
- Medication Therapy Management ServicesDrugs, 2009
- A Manual of Guidelines to Score the Modified Cumulative Illness Rating Scale and Its Validation in Acute Hospitalized Elderly PatientsJournal of the American Geriatrics Society, 2008
- Clinical medication review by a pharmacist of elderly people living in care homes—randomised controlled trialAge and Ageing, 2006
- MEDICATION APPROPRIATENESS INDEX: RELIABILITY AND RECOMMENDATIONS FOR FUTURE USEJournal of the American Geriatrics Society, 2006
- A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validityJournal of Clinical Epidemiology, 1994
- A method for assessing drug therapy appropriateness☆Journal of Clinical Epidemiology, 1992